Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins

Journal of Viral Hepatitis

Volumn 13, Issue 1, 2006, Pages 47-55

  Sarobe, P ^a,b   Lasarte, J J ^a   Garcia N ^a   Civeira, M P ^a   Borras Cuesta F ^a   Prieto, J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Hepatitis C virus; IFN therapy; Immunodominant epitopes; Peptides; T helper responses

Indexed keywords

ALPHA INTERFERON; EPITOPE; HEPATITIS C VACCINE; INTERLEUKIN 2; NONSTRUCTURAL PROTEIN 4A; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; GLYCOPROTEIN E2, HEPATITIS C VIRUS; HLA DR ANTIGEN; NS4 PROTEIN, HEPATITIS C VIRUS; PEPTIDE FRAGMENT; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; AMINO ACID SEQUENCE; CHEMISTRY; DRUG EFFECT; GENETICS; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; VIROLOGY;

ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; HEPACIVIRUS; HEPATITIS C; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERLEUKIN-2; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RNA, VIRAL; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 33644874578     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00653.x     Document Type: Article

References (51)

1. Choo QL Kuo G Weiner AJ Overby LR Bradley DW Houghton M Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 1989 244 359 362
2. Dienstag JL Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features Gastroenterology 1983 85 439 462
3. World Health Organization Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium J Viral Hepat 1999 6 35 47
4. Poynard T Marcellin P Lee SS et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 1998 352 1426 1432
5. McHutchison JG Gordon SC Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group N Engl J Med 1998 339 1485 1492
6. Botarelli P Brunetto MR Minutello MA et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection Gastroenterology 1993 104 580 587
7. Diepolder HM Zachoval R Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 1995 346 1006 1007
8. Missale G Bertoni R Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J Clin Invest 1996 98 706 714
9. Takaki A Wiese M Maertens G et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 2000 6 578 582
10. Lechner F Wong DK Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus J Exp Med 2000 191 1499 1512
11. Gruener NH Gerlach TJ Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C J Infect Dis 2000 181 1528 1536
12. Chang KM Thimme R Melpolder JJ et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection Hepatology 2001 33 267 276
13. Tsai SL Liaw YF Chen MH Huang CY Kuo GC Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity Hepatology 1997 25 449 458
14. Cramp ME Carucci P Rossol S et al. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia Gut 1999 44 424 429
15. Sarobe P Lasarte JJ Golvano JJ et al. Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr J Acquir Immune Defic Syndr 1994 7 635 640
16. Lasarte JJ Sarobe P Gullon A Prieto J Borras Cuesta F Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct Cell Immunol 1992 141 211 218
17. Bennett SR Carbone FR Karamalis F Flavell RA Miller JF Heath WR Help for cytotoxic-T-cell responses is mediated by CD40 signalling Nature 1998 393 478 480
18. Ridge JP Di Rosa F Matzinger P A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell Nature 1998 393 474 478
19. Schoenberger SP Toes RE van der Voort EI Offringa R Melief CJ T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 1998 393 480 483
20. Janssen EM Lemmens EE Wolfe T Christen U von Herrath MG Schoenberger SP CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes Nature 2003 421 852 856
21. Godkin AJ Thomas HC Openshaw PJ Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus J Immunol 2002 169 2210 2214
22. Day CL Seth NP Lucas M et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers J Clin Invest 2003 112 831 842
23. Grakoui A Shoukry NH Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help Science 2003 302 659 662
24. Lechmann M Ihlenfeldt HG Braunschweiger I et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia Hepatology 1996 24 790 795
25. Diepolder HM Gerlach JT Zachoval R et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection J Virol 1997 71 6011 6019
26. Lamonaca V Missale G Urbani S et al. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development Hepatology 1999 30 1088 1098
27. Germain RN Margulies DH The biochemistry and cell biology of antigen processing and presentation Annu Rev Immunol 1993 11 403 450
28. Large MK Kittlesen DJ Hahn YS Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence J Immunol 1999 162 931 938
29. Kittlesen DJ Chianese-Bullock KA Yao ZQ Braciale TJ Hahn YS Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation J Clin Invest 2000 106 1239 1249
30. Hahn CS Cho YG Kang BS Lester IM Hahn YS The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line Virology 2000 276 127 137
31. Bergqvist A Rice CM Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein J Virol 2001 75 772 781
32. Sarobe P Lasarte JJ Casares N et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins J Virol 2002 76 5062 5070
33. Dolganiuc A Kodys K Kopasz A et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation J Immunol 2003 170 5615 5624
34. Sarobe P Lasarte JJ Zabaleta A et al. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses J Virol 2003 77 10862 10871
35. Brady MT MacDonald AJ Rowan AG Mills KH Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes Eur J Immunol 2003 33 3448 3457
36. Sarobe P Jauregui JI Lasarte JJ et al. Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment J Hepatol 1996 25 1 9
37. Lasarte JJ Garcia Granero M Lopez A et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C Hepatology 1998 28 815 822
38. Hoffmann RM Diepolder HM Zachoval R et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection Hepatology 1995 21 632 638
39. Missale G Cariani E Lamonaca V et al. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients Hepatology 1997 26 792 797
40. Hultgren C Desombere I Leroux-Roels G et al. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses J Hepatol 2004 40 971 978
41. Francavilla V Accapezzato D De Salvo M et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms Eur J Immunol 2004 34 427 437
42. Cramp ME Rossol S Chokshi S Carucci P Williams R Naoumov NV Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C Gastroenterology 2000 118 346 355
43. Harcourt GC Lucas M Godkin AJ Kantzanou M Phillips RE Klenerman P Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection Clin Exp Immunol 2003 131 122 129
44. Minutello MA Pileri P Unutmaz D et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C J Exp Med 1993 178 17 25
45. Ferrari C Valli A Galati L et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections Hepatology 1994 19 286 295
46. Tsai SL Chen PJ Hwang LH et al. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection J Hepatol 1994 21 403 411
47. Kuo G Choo QL Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 1989 244 362 364
48. Schupper H Hayashi P Scheffel J et al. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C Hepatology 1993 18 1055 1060
49. Day CL Lauer GM Robbins GK et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection J Virol 2002 76 12584 12595
50. Wertheimer AM Miner C Lewinsohn DM Sasaki AW Kaufman E Rosen HR Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection Hepatology 2003 37 577 589
51. Borras-Cuesta F Golvano J Garcia-Granero M et al. Specific and general HLA-DR binding motifs: comparison of algorithms Hum Immunol 2000 61 266 278